Recommended Conferences

  • 3rd International Conference on Biopharmaceutics and Biologic Drugs
    June 19-20, 2017 Philadelphia, USA
  • 3rd International Conference and Expo on Drug Discovery & Designing
    September 25-27, 2017 Vienna ,Austria
  • 3rd International Conference on Genomics and Toxicogenomics
    September 27-28, 2017 Chicago, USA
  • 11th World Drug Delivery Summit
    October 16-18, 2017 New York, USA
  • 9th Annual Congress  on Drug Formulation & Drug Design
    October 19-21, 2017 Seoul, South Korea

Andreas Bernkop Schnurch

Andreas Bernkop Schnurch
University of Innsbruck, Innsbruck, Austria
Andreas Bernkop-Schnürch was educated in pharmacy at the Institute of Pharmacy (M.Sc.) and in microbiology and genetics at the Institute of Microbiology and Genetics (D.Sc.), University of Vienna, Austria. In 2003 he was appointed to a chair in pharmaceutical technology at the University of Innsbruck. He is a leading scientist of multifunctional polymers in the field of drug delivery and therapy. Andreas Bernkop-Schnürch invented and pioneered thiolated polymers ? thiomers ? as a new generation of mucoadhesive excipients. He is author of over 350 research articles and reviews. As of November 2016 his publications have been cited over 14,000 and his H-index is 61. Andreas Bernkop-Schnürch is member of the Scientific Committee of the Innovative Medicines Initiative (IMI) of the European Union in Brussels, Belgium and founder of various companies including Mucobiomer GmbH (now part of the Croma-Pharma GmbH), Thiomatrix Forschungs- und Beratungs GmbH and Green River Polymers Forschungs und Entwicklungs GmbH.
Research Interest
Nonotechnology Mucoadhesive polymers Biomaterials Multifunctional polymers Self-emulsifying drug delivery systems

Relevant Conferences